COVID-19 Science Report: Therapeutics

COVID-19 Science Report: Therapeutics

10.25540/qqrk-bpcs

Saved in:

Bibliographic Details
Main Authors:	Jason Chin-Huat YAP, Ian Yi Han ANG, Sharon Hui Xuan TAN, Jacinta I-Pei CHEN, Ruth Frances LEWIS, Qian YANG, Rowena Kah Sin YAP, Bob Xian Yi NG, Hao Yi TAN
Other Authors:	DEAN'S OFFICE (SSH SCH OF PUBLIC HEALTH)
Format:	Working Paper/Technical Report
Published:	2020
Subjects:	COVID-19 SARS-CoV-2 2019-nCoV COVID19 coronavirus therapeutics drug therapy medication interferons Lopinavir Ritonavir Kaeltra umifenovir arbidol Remdesivir Chloroquine Ribavirin Corticosteroids Convalescent Plasma
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/164813
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Role of adjunctive treatment strategies in COVID-19 and a review of international and national clinical guidelines
by: Xu, X., et al.
Published: (2021)

COVID-19 Science Report: Vaccines
by: Jason Chin-Huat YAP, et al.
Published: (2020)

COVID-19 Science Report: Clinical Characteristics
by: Jason Chin-Huat YAP, et al.
Published: (2020)

COVID-19 Science Report: Diagnostics
by: Jason Chin-Huat YAP, et al.
Published: (2020)

COVID-19 Science Report: Social Distancing & Lockdowns
by: Jason Chin-Huat YAP, et al.
Published: (2020)

Co-incidence of BA.1 and BA.2 at the start of Singapore's Omicron wave revealed by community and university campus wastewater surveillance
by: Chua, Desmond Feng Jun, et al.
Published: (2023)

Coronavirus disease 2019 (COVID-19) pandemic and pregnancy
by: Dashraath, Pradip, et al.
Published: (2023)

Importations of COVID-19 into African countries and risk of onward spread
by: Sun, H., et al.
Published: (2021)

Neurology of COVID-19 in Singapore
by: Koh, JS, et al.
Published: (2020)

COVID-19 Science Report: Exit Strategies & Scenarios
by: Jason Chin-Huat YAP, et al.
Published: (2020)

Combination therapy using inhalable GapmeR and recombinant ACE2 for COVID-19
by: Verma, Navin Kumar, et al.
Published: (2020)

Extrapulmonary manifestations and complications of severe acute respiratory syndrome coronavirus 2 infection: a systematic review.
by: Cho, Jiacai, et al.
Published: (2021)

Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development
by: de Alwis, R., et al.
Published: (2021)

Results from a systematic programme of evaluating COVID-19 reinfection cases in the early phase of the pandemic, Singapore
by: Tan, Glorijoy Shi En, et al.
Published: (2023)

Waning of specific antibodies against Delta and Omicron variants five months after a third dose of BNT162b2 SARS-CoV-2 vaccine in elderly individuals
by: Goh, Yun Shan, et al.
Published: (2023)

Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC]
by: Poh, Xuan Ying, et al.
Published: (2023)

Laboratory practice in the face of Covid-19
by: Lau, C.S., et al.
Published: (2021)

Temporal dynamics of the host molecular responses underlying severe COVID-19 progression and disease resolution
by: Ong, Eugenia Z., et al.
Published: (2022)

Asymptomatic COVID-19: disease tolerance with efficient anti-viral immunity against SARS-CoV-2
by: Chan, Yi-Hao, et al.
Published: (2022)

How Should the Rehabilitation Community Prepare for 2019-nCoV?
by: Choon-Huat Koh, G, et al.
Published: (2022)

Environmental contamination of SARS-CoV-2 in a non-healthcare setting
by: Wong, Judith Chui Ching, et al.
Published: (2021)

Facing a disruptive threat: how can a nuclear medicine service be prepared for the coronavirus outbreak 2020?
by: Lam, Winnie Wing-Chuen, et al.
Published: (2023)

Dicoumarol is an effective post-exposure prophylactic for SARS-CoV-2 Omicron infection in human airway epithelium.
by: Peng, Yang, et al.
Published: (2023)

Vaccines and allergic reactions: The past, the current COVID-19 pandemic, and future perspectives
by: Sampath, V, et al.
Published: (2022)

Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity
by: Amrun, S.N., et al.
Published: (2021)

The identification and phylogenetic analysis of SARS-CoV-2 delta variants in Taiwan
by: Liu, LT, et al.
Published: (2023)

SARS-CoV-2 titers in wastewater are higher than expected from clinically confirmed cases
by: Wu, F., et al.
Published: (2021)

Effectiveness of vaccination against SARS-CoV-2 and the need for alternative preventative approaches in immunocompromised individuals: a narrative review of systematic reviews
by: Tan, TT, et al.
Published: (2023)

COVID-19 and Airborne Transmission: Science Rejected, Lives Lost. Can Society Do Better?
by: Morawska, Lidia, et al.
Published: (2023)

COVID-19 Science Report: Country Journeys
by: Jason Chin-Huat YAP, et al.
Published: (2020)

Coronaviridae—Old friends, new enemy!
by: Leao, JC, et al.
Published: (2022)

Insights into the first seven-months of COVID-19 pandemic in Bangladesh: lessons learned from a high-risk country
by: Siam, Md. Hasanul Banna, et al.
Published: (2022)

Calculating the serial interval of SARS-CoV-2 in Lebanon using 2020 contact-tracing data
by: Haddad, N, et al.
Published: (2021)

Positive anti-SSA/Ro antibody in a woman with SARS-CoV-2 infection using immunophenotyping: A case report
by: Huang, P.-I., et al.
Published: (2021)

Rapid production of clinical-grade SARS-CoV-2 specific T cells.
by: Leung, Wing, et al.
Published: (2022)

Global haemostatic tests demonstrate the absence of parameters of hypercoagulability in non-hypoxic mild COVID-19 patients: a prospective matched study
by: Fan, Bingwen Eugene, et al.
Published: (2021)

Age-Related Differences in Immunological Responses to SARS-CoV-2
by: LYDIA WONG SU YIN, et al.
Published: (2020)

Occupational health responses to COVID-19: What lessons can we learn from SARS?
by: Koh, D., et al.
Published: (2021)

Response to Letter Regarding “How Should the Rehabilitation Community Prepare for 2019-nCoV?”
by: Hoenig, H, et al.
Published: (2022)

The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak- A n update on the status
by: Guo, Y.-R., et al.
Published: (2021)